RemSleep Holdings: Going-concern warning, $23.9K cash
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
RemSleep Holdings Inc. (RMSL) reported no revenue for the nine months ended September 30, 2026, versus $12,278 a year earlier, and a net loss of $405,103, compared with $2,685,406.
Operating cash use was $403,915 versus $373,395. At September 30, cash was $23,947 and working capital deficit was $218,608, compared with $214,514 cash and a $34,448 deficit at December 31, 2025. The company said these conditions raise substantial doubt about its ability to continue as a going concern. Additional financing and revenue growth are needed, but planned financing and e-commerce efforts may not succeed.
Disclosure controls were not effective as of September 30, 2026, due to a lack of segregation of duties. 1000152403 Ontario Inc. acquired substantially all of the preferred-stock control block on May 27, 2026. Sanja Pekovic became president and CEO; Peter Downey was appointed interim president on June 1, 2026, while Pekovic remained CEO. Quick Capital converted a $68,125 note into 132,406,619 common shares on August 17, 2026. On September 2, 2026, the board approved 45,000,000 restricted shares for services and compensation claims; no cash proceeds were received.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointNine-month net loss decreased to $405,103 from $2,685,406.
Negative
- Major pointThe company said substantial doubt exists about its ability to continue as a going concern.
- Moderate pointOperating cash use was $403,915, versus $373,395 a year earlier.
- Minor pointNine-month revenue was $0, versus $12,278 a year earlier.
Filing Explained
The filing reports
Key Figures
Key Terms
going concern financial
working capital deficit financial
CECL model financial
Level 3 inputs financial
derivative liability financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much revenue did RMSL report for the nine months ended September 30, 2026?
What did RMSL say about its ability to continue operating?
How many shares did RMSL issue in the Quick Capital note conversion?
AI-generated analysis. How Rhea-AI works. Not financial advice.
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For the quarterly period ended
or
For the transition period from ____________ to ____________
Commission File Number:
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| ☒ | Smaller reporting company | ||
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| OTC Pink |
Indicate the number of shares outstanding of each
of the issuer’s classes of common stock, as of the latest practicable date: as of November 13, 2026, there were
TABLE OF CONTENTS
| Page | ||
| PART I – FINANCIAL INFORMATION | 3 | |
| Item 1. | Financial Statements | F-1 |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 4 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 8 |
| Item 4. | Controls and Procedures | 8 |
| PART II – OTHER INFORMATION | 9 | |
| Item 1. | Legal Proceedings | 9 |
| Item 1A. | Risk Factors | 9 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 9 |
| Item 3. | Defaults Upon Senior Securities | 9 |
| Item 4. | Mine Safety Disclosures | 9 |
| Item 5. | Other Information | 9 |
| Item 6. | Exhibits | 10 |
| Signatures | 11 |
| 2 |
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
REMSLEEP HOLDINGS, INC.
Balance Sheets as of September 30, 2026 (unaudited) and December 31, 2025 (audited) |
F-1 |
| Statements of Operations for the Nine Months Ended September 30, 2026 and 2025 (unaudited) | F-2 |
| Statements of Stockholders’ Equity (Deficit) for the Nine Months Ended September 30, 2026 and 2025 (unaudited) | F-3 |
| Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 (unaudited) | F-4 |
| Notes to the Financial Statements (unaudited) | F-5 |
| 3 |
REMSLEEP HOLDINGS, INC.
BALANCE SHEET
(UNAUDITED)
| As of Sept 30, 2026 (Unaudited) | As of December 31, 2025 | |||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and Bank | $ | $ | ||||||
| Inventory | $ | $ | ||||||
| Prepaid Expenses | $ | $ | ||||||
| Total current assets | $ | $ | ||||||
| Non-Current Asset | ||||||||
| Other Assets | $ | $ | ||||||
| Right of use assets | $ | $ | ||||||
| Property and Equipment, net | $ | $ | ||||||
| TOTAL ASSETS | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current Liabilities | ||||||||
| Bank Overdraft | $ | $ | ||||||
| Account Payable | $ | $ | ||||||
| Accrued Compensation | $ | $ | ||||||
| Convertible Notes Payable | $ | $ | ||||||
| Derivative Liability | $ | $ | ||||||
| Convertible Notes Payable- Interest Accrued | $ | $ | ||||||
| Operating Lease Liability- Current Portion | $ | $ | ||||||
| Total current liabilities | $ | $ | ||||||
| Non-Current Liabilities | ||||||||
| Operating Lease Liability-Net Current Portion | $ | $ | ||||||
| Total other liabilities | $ | $ | ||||||
| TOTAL LIABILITIES | $ | $ | ||||||
| Stockholders' Equity | ||||||||
| Common Stock. $ | $ | $ | ||||||
| Series A preferred stock, $ | $ | $ | ||||||
| Series B preferred stock, $ | $ | $ | ||||||
| Series C preferred stock, $ | $ | $ | ||||||
| Discount to Common Stock | $ | ( | ) | $ | ( | ) | ||
| Additional paid-in-capital | $ | $ | ||||||
| Accumulated deficit | $ | ( | ) | $ | ( | ) | ||
| TOTAL STOCKHOLDERS' EQUITY | $ | ( | ) | $ | ||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited financial statements.
| F-1 |
REMSLEEP HOLDINGS, INC.
STATEMENTS OF OPERATIONS
FOR THE NINE AND THREE MONTH ENDED SEPT 30, 2026
(UNAUDITED)
For the Three Month Period Ended Sept 30, | For the Nine Month Period Ended Sept 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Operating revenue: | ||||||||||||||||
| Revenues | $ | $ | $ | $ | ||||||||||||
| Cost of revenues | $ | $ | ( | ) | $ | $ | ( | ) | ||||||||
| Gross Profit | $ | $ | $ | $ | ||||||||||||
| Operating expenses: | $ | |||||||||||||||
| Professional Fees | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
| Compensation Expenses | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
| Development Expenses | $ | $ | $ | $ | ( | ) | ||||||||||
| Lease Expenses | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
| General and Administrative Expenses | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Total operating expenses | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Loss from operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Other Income (expenses) | ||||||||||||||||
| Interest Expenses | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Loss on Issuance of Convertible Debt | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||
| Gain/(Loss) on Conversion of Debt | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
| Change in Fair value of derivative | $ | $ | $ | $ | ||||||||||||
| Total other income/(expense) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Net Loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Net Loss Per Share | ||||||||||||||||
| Basic and Diluted | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted Average Shares Outstanding | ||||||||||||||||
| Basic and Diluted | ||||||||||||||||
The accompanying notes are an integral part of these unaudited financial statements.
| F-2 |
REMSLEEP HOLDINGS, INC.
STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
(Unaudited)
| Description | Shares | Common Stock | Preferred Stock(A) | Preferred Stock(A) | Preferred Stock(B) | Preferred Stock(B) | Preferred Stock(C) | Preferred Stock(C) | Discount to Common Stock | Additional Paid-in Capital | Accumulated Deficit | Total | ||||||||||||||||
| $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
| Balance – Balance Jan 1, 2025 | ( | ) | ( | ) | ||||||||||||||||||||||||
| Common stock issued for warrant | – | – | – | ( | ) | |||||||||||||||||||||||
| Share Issued for services- Related Party | – | – | – | – | – | – | – | – | ||||||||||||||||||||
| Common stock issued for debt | – | – | – | – | – | – | – | – | ||||||||||||||||||||
| Net (loss) | – | – | – | – | – | – | – | – | – | – | ( | ) | ( | ) | ||||||||||||||
| Balance – Dec 31, 2025 | ( | ) | ( | ) | ||||||||||||||||||||||||
| Balance – Balance Jan 1, 2026 | ( | ) | ( | ) | ||||||||||||||||||||||||
| Common stock issued for debt | – | – | – | – | – | – | – | – | – | |||||||||||||||||||
| Additional Paid-in Capital | – | – | – | – | – | – | – | – | – | – | ||||||||||||||||||
| Preferred Stock (B) | – | – | – | | – | | ||||||||||||||||||||||
| Assets(Bond) Cancelled /Expired | – | – | – | | – | | ||||||||||||||||||||||
| Net (loss) | – | – | – | – | – | – | – | – | – | ( | ) | ( | ) | |||||||||||||||
| Balance – Sept 30, 2026 | ( | ) | ( | ) | ( | ) |
The accompanying notes are an integral part of these unaudited financial statements.
| F-3 |
REMSLEEP HOLDINGS, INC.
STATEMENTS OF CASH FLOWS
(Unaudited)
| Period Ended Sept 30, 2026 | Period Ended Sept 30, 2025 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss from continuing operations attributable to | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net Income (loss) to net cash | ||||||||
| Depreciation/Amortization | $ | $ | ||||||
| Change in fair value of derivative | $ | ( | ) | $ | ( | ) | ||
| Loss on issuance of convertible debt | $ | $ | ||||||
| Amortization and Non-cash expenses | $ | ( | ) | $ | ||||
| Loss on Conversion of debt | $ | ( | ) | $ | ||||
| Operating Lease Expense | $ | $ | ||||||
| Bad Debt Expense | $ | $ | ||||||
| Preferred Stock Issued for Service Related | $ | $ | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Decrease / (Increase) in Operating Lease Liabilities | $ | ( | ) | $ | ||||
| Decrease / (Increase) in Inventory | $ | ( | ) | $ | ( | ) | ||
| Decrease / (Increase) in deposit on inventory | $ | $ | ||||||
| Decrease / (Increase) in prepaid and other assets | $ | $ | ||||||
| Decrease / (Increase) in accounts payable | $ | ( | ) | $ | ||||
| Decrease / (Increase) in accrued compensation | $ | $ | ||||||
| Decrease / (Increase) in notes payable | $ | $ | ( | ) | ||||
| Decrease / (Increase) in accrued interest | $ | $ | ||||||
| Decrease / (Increase) in Derivative Liability | $ | $ | ||||||
| Cash flow from Operating Activities | $ | ( | ) | $ | ( | ) | ||
| Cash flows from investing activities | ||||||||
| Additional in fixed assets | $ | $ | ||||||
| Net cash used in investing activities | $ | $ | ||||||
| Cash flows from financing activities | ||||||||
| Proceeds from Convertible Note Payable | $ | $ | ||||||
| Additional paid in capital | $ | $ | ||||||
| Common Stock Issued During the year | $ | $ | ||||||
| Net cash provided by financing activities | $ | $ | ||||||
| Net increase in cash | $ | ( | ) | $ | ( | ) | ||
| Cash, beginning of period | $ | $ | ||||||
| Cash, end of period | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited financial statements.
| F-4 |
REMSLEEP HOLDINGS, INC.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
SEPTEMBER 30, 2026
NOTE 1 – BACKGROUND
Business Activity
REMSleep Holdings, Inc., (the “Company”) was incorporated in the State of Nevada on September 6, 2007. On January 5, 2015 the name of the Company was changed to REMSleep Holdings, Inc. and the business model was changed to reflect the new direction of the Company; to develop and distribute products to help people affected by sleep apnea. On May 30, 2015, REMSleep LLC was formally merged into REMSleep Holdings, Inc.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Concentrations of Credit Risk
We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”).
Cash Equivalents
The Company considers all highly liquid investments
with a maturity of nine months or less when purchased to be cash equivalents. There were
Property and Equipment
Fixed assets are carried at the lower of cost or net realizable value. All fixed assets with a cost of $2,000 or greater are capitalized. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful lives of the assets, which range from three to five years. Leasehold improvements are amortized over the lesser of the remaining term of the lease or the estimated useful life of the asset. Major betterments that extend the useful lives of assets are also capitalized. Normal maintenance and repairs are charged to expense as incurred. When assets are sold or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in operations.
| F-5 |
Shipping and Handling Costs
Shipping and handling costs consist of expenses incurred to transport products to customers (“outbound freight”) and costs incurred to acquire inventory from suppliers (“inbound freight”). Inbound freight costs incurred to transport inventory from suppliers to the Company’s facilities are capitalized as a component of inventory and are recognized in cost of goods sold when the related inventory is sold. Outbound shipping and handling costs incurred to deliver products to customers are classified as operating expenses within general and administrative Expenses in the accompanying Statements of Operations.
Basic and Diluted Earnings Per Share
Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. Diluted amounts are not presented when the effect of the computations are anti-dilutive due to the losses incurred. Accordingly, there is no difference in the amounts presented for basic and diluted loss per share.
As of September 30, 2026, the Company
had approximately
As of December 31, 2025, the Company
had approximately
Stock-Based Compensation
We account for equity-based transactions with employees and non-employees under the provisions Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) of ASC Topic 718, “Compensation – Stock Compensation” (“Topic 718”), which establishes that equity-based payments to employees and non-employees are recorded at the grant date the fair value of the equity instruments the entity is obligated to issue when the employees and non-employees have rendered the requisite service and satisfied any other conditions necessary to earn the right to benefit from the instruments. Topic 718 also states that observable market prices of identical or similar equity or liability instruments in active markets are the best evidence of fair value and, if available, should be used as the basis for the measurement for equity and liability instruments awarded in these share-based payment transactions. However, if observable market prices of identical or similar equity or liability instruments are not available, the fair value shall be estimated by using a valuation technique or model that complies with the measurement objective, as described in Topic 718.
Fair Value of Financial Instruments
The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP) and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into Six broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The Six levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
| F-6 |
Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data.
The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses, accounts payable and accrued expenses approximate their fair value because of the short maturity of those instruments. The Company’s notes payable approximate the fair value of such instruments as the notes bear interest rates that are consistent with current market rates.
| Schedule of financial assets and liabilities | ||||||||||||||||
Total Fair Value at 2026 | Quoted prices in active markets | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | |||||||||||||
| Derivative liabilities | $ | $ | $ | $ | ||||||||||||
Total Fair Value at 2025 | Quoted prices in active markets | Significant other observable inputs (Level 2) | Significant unobservable inputs (Level 3) | |||||||||||||
| Derivative liabilities | $ | $ | $ | $ | ||||||||||||
Revenue Recognition
The Company recognizes revenue under ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps:
| ● | Identification of a contract with a customer; | |
| ● | Identification of the performance obligations in the contract; | |
| ● | Determination of the transaction price; | |
| ● | Allocation of the transaction price to the performance obligations in the contract; and | |
| ● | Recognition of revenue when or as the performance obligations are satisfied. |
Revenue is recognized at the point in time when control of the promised goods transfers to the customer, which occurs upon shipment. Payment terms are net 30 days.
| F-7 |
Warranties
Up until December 31, 2024, the
Company was selling its ResPlus Auto CPAP Machine (“ResPlus”). The ResPlus is imported by the Company and sold primarily to
Durable Medical Equipment companies to patients with sleep apnea. The manufacturer warranties the unit for
Accounts Receivable and Allowance for Credit Losses
Revenues that have been recognized but not yet received are recorded as accounts receivable. The Company estimates its allowance for credit losses using the Current Expected Credit Loss (CECL) model under ASC 326. The CECL model requires recognition of expected credit losses over the contractual life of financial assets held at the reporting date, considering the nature of debt, industry expectations, current conditions, and reasonable and supportable forecasts.
Financial assets subject to CECL include trade receivables, if any. The Company groups financial assets based on shared risk characteristics and evaluates them collectively. The allowance is measured using a combination of historical activity, industry expectations, adjusted for current economic trends and forward- looking factors such as industry outlook and macroeconomic indicators (e.g., unemployment rate, GDP).
Under CECL, the carrying amount of a financial asset (net of the allowance for credit losses) represents the amount the Company expects to collect. This means that when the CECL estimate is appropriately recorded, the net reported balance of financial assets reflects management’s best estimate of collectible cash flows, based on available and supportable information.
Management reviews the adequacy of the allowance at each reporting period and updates estimates as appropriate. Changes in estimates are recorded in the income statement as a component of credit loss expense.
As of September 30, 2026 and December
31, 2025, there are
Inventories
Inventories are stated at the lower
of cost or net realizable value. Inventory on hand consists of finished goods purchased from third parties. When there is evidence that
the inventory’s value is less than original cost, the inventory is reduced to market value. We determine market value on current
resale amounts and whether technological obsolescence exists. As of September 30, 2026 and December 31, 2025, there is $
Recently Adopted Accounting Pronouncements
The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.
| F-8 |
NOTE 3 – GOING CONCERN
The accompanying unaudited financial
statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities
in the normal course of business. The Company has an accumulated deficit of $
On or about June 1, 2026, the Company began implementing certain operational and administrative changes in connection with its transition plan under new management. The Company has closed its former office located in Georgia and has relocated its principal office operations to Florida. In connection with the relocation, the Company has also established a new warehouse facility in Florida to support its ongoing business operations located at 1900 6th Ave, South Lake Worth, FL 33461. The Company is transitioning its business model away from the prior retail “cash and carry” walk-in traffic model in the rural town of Blackshear, Georgia, toward a business model focused more heavily based on Internet e-commerce and e-retail sales channels such as eBay and similar e- tailers launching nationwide and then moving on to international markets.
NOTE 4 – PROPERTY & EQUIPMENT
Long lived assets, including property and equipment and certain intangible assets to be held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Impairment losses are recognized if expected future cash flows of the related assets are less than their carrying values. Measurement of an impairment loss is based on the fair value of the asset. Long-lived assets and certain identifiable intangibles to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.
Property and Equipment and intangible assets are first recorded at cost. Depreciation and/or amortization is computed using the straight-line method over the estimated useful lives of the various classes of assets as follows between Three and five years.
Maintenance and repair expenses, as incurred, are charged to expense. Betterments and renewals are capitalized in plant and equipment accounts. Cost and accumulated depreciation applicable to items replaced or retired are eliminated from the related accounts with any gain or loss on the disposition included as income.
Assets stated at cost, less accumulated depreciation consisted of the following:
| Schedule of property and equipment | ||||||||
September 30, 2026 | December 31, 2025 | |||||||
| Furniture/fixtures | $ | $ | ||||||
| Office equipment | ||||||||
| Automobile | ||||||||
| Tooling/Molds | ||||||||
| Less: accumulated depreciation | ( | ) | ( | ) | ||||
| Fixed assets, net | $ | $ | ||||||
| F-9 |
Depreciation expense
Depreciation expense for the Nine months
ended September 30, 2026 and 2025 was $
NOTE 5 – CONVERTIBLE NOTE PAYABLE
On June 10, 2025, the Company issued
a
On August 15, 2025, the
Company issued a
On January 27, 2026, the Company
issued a
On
June 17th, 2026, RemSleep Holding, Inc signed a convertible loan agreement with Fransys Consulting Inc. a company located at 500 S Australian
Ave., West Palm Beach FL 33401 USA and obtained a loan of $
A summary of the activity of the derivative liability for the notes above is as follows:
| Schedule of derivative liability | ||||
| Balance at December 31, 2024 | $ | |||
| Increase to derivative due to new issuances | ||||
| Decrease to derivative due to conversion/repayments | ( | ) | ||
| Derivative gain due to mark to market adjustment | ( | ) | ||
| Balance at December 31, 2025 | ||||
| Increase to derivative due to new issuances | ||||
| Decrease to derivative due to conversion/repayments | ( | ) | ||
| Derivative gain due to mark to market adjustment | ( | ) | ||
| Balance at September 30, 2026 | $ |
| F-10 |
A summary of quantitative information about significant unobservable inputs (Level 3 inputs) used in measuring the Company’s derivative liability that are categorized within Level 3 of the fair value hierarchy as of September 30, 2026 and December 31, 2025 is as follows:
| Schedule of fair value derivative liability | ||||||||||||
| Inputs | September 30, 2026 | December 31, 2025 | Initial Valuation | |||||||||
| Stock price | $ | $ | $ | |||||||||
| Conversion price | $ | $ | $ | |||||||||
| Volatility (annual) | ||||||||||||
| Risk-free rate | ||||||||||||
| Dividend rate | – | – | – | |||||||||
| Years to maturity | ||||||||||||
NOTE 6 – RELATED PARTY TRANSACTIONS
The Company executed a
new employment agreement with Mr. Wood on January 1, 2025. Per the terms of the agreement Mr. Wood was to be compensated $9,000
per month. During the nine months ended September 30, 2026 and 2025, cash payments of $
During the Nine months ended September
30, 2026 and 2025, the Company paid $
Effective March 2, 2026, Anita Michaels, the sole surviving member of the Board following Mr. Wood’s passing, COO, and his sister, acted by written consent in lieu of a meeting to reconstitute the Board. Mrs. Michaels elected herself as Chairman of the Board and appointed Jeffrey Marshall, and Alexander Johnson as directors. Mr. Marshall was also appointed as the new CEO. Refer to Note 12 for subsequent change of control and management.
During the Nine months ended September
30, 2026, the Company incurred $
During the Nine months ended September
30, 2026, the Company paid $
| F-11 |
NOTE 7 – OPERATING LEASES
The Company entered into a New Lease Agreement (the “Lease”)
with Tuck property, LLC (the “Lessor”), effective June 1, 2025, relating to approximately
| Schedule of operating leases | ||||||||||
| Balance Sheet Classification | September 30, 2026 | December 31, 2025 | |||||||
| Asset | ||||||||||
| Operating lease asset | Right of use asset | $ | $ | |||||||
| Total lease asset | ||||||||||
| Liability | ||||||||||
| Operating lease liability – current portion | Current operating lease liability | |||||||||
| Operating lease liability – noncurrent portion | Long-term operating lease liability | |||||||||
| Total lease liability | $ | $ | ||||||||
Lease obligation at September 30, 2026 consisted of the following:
| Schedule of lease maturity | ||||
For the year ended December 31: | ||||
| 2026 | $ | |||
| 2027 | ||||
| Total payments | ||||
| Amount representing interest | ( | ) | ||
| Lease obligation, net | ||||
| Less current portion | ( | ) | ||
| Lease obligation – long term | $ | |||
The operating lease expense for the
above agreement for the nine months ended September 30, 2026, was $
NOTE 8 – COMMON STOCK TRANSACTIONS
During the nine months ended September
30, 2026, 1800 Diagonal converted $
During the nine months
ended September 30, 2026, Itai for Remsleep Holdings for Quick Capital Holdings LLC, with a securities Purchase agreement and and
ITAI for $
| F-12 |
NOTE 9 – PREFERRED STOCK
The Company is currently authorized
to issue
The Company is currently authorized
to issue
The Company is currently authorized
to issue
NOTE 10 – INCOME TAX
The Company accounts for income taxes in accordance with ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial statement carrying amounts and the tax bases of assets and liabilities, as well as for net operating loss carryforwards.
For the nine months ended September
30, 2026 and 2025, the Company recorded
As of September 30, 2026, the Company
had federal net operating loss carryforwards of approximately $
The effective tax rate for the nine months ended September 30, 2026 and 2025 differed from the statutory federal income tax rate primarily due to the increase in the valuation allowance recorded against deferred tax assets.
The components of the Company’s effective tax rate reconciliation are as follows:
| Schedule of effective tax rate reconciliation | ||||||||
| September 30, 2026 | September 30, 2025 | |||||||
| Federal statutory tax rate | ||||||||
| State taxes, net of federal benefit | ||||||||
| Change in valuation allowance | ( | ) | ( | ) | ||||
| Effective tax rate | ||||||||
The Company recognizes interest
and penalties related to uncertain tax positions in income tax expense. As of September 30, 2026, the Company had
| F-13 |
NOTE 11 - SEGMENT REPORTING
ASC Topic 280, “Segment Reporting” establishes the standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about services categories, business segments and major customers in financial statements. The Company is managed as one operating unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making and discloses its operating results in a single reportable segment. The Company’s chief operating decision maker (“CODM”), represented by the Company’s Chief Executive Officer, reviews financial information and assesses the operations of the Company in order to make strategic decisions such as allocation of resources and assessing operating performance.
NOTE 12 – SUBSEQUENT EVENTS
In accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial statements were available to be issued and has determined that it has the following material subsequent event to disclose in these financial statements.
On May 27, 2026, the Company experienced a change in control following private off-market transactions in which 1000152403 Ontario Inc. acquired substantially all of the Company's preferred stock control block through purchases and assignments from existing preferred shareholders. The Board accepted the resignations of Jeffrey Todd Marshall as Chief Executive Officer, Anita L. Michaels as Chief Operating Officer and Chairman of the Board, and Roman Israel Wood as President, Treasurer and Secretary. The resignations were effective May 27, 2026. At the same time, the Board appointed Teresita Rubio as Treasurer and Chairman of the Board, Sanja Pekovic as President and Chief Executive Officer, and Irina Veselinovic as Secretary, effective May 27, 2026.
On June 1, 2026, the Company appointed Peter Downey as Interim President while Sanja Pekovic continued as Chief Executive Officer. Additionally, on September 2, 2026, the Board approved equity-based compensation arrangements consisting of the issuance of 15,000,000 restricted common shares to Scott Hasselbring for services related to asset preservation and estate administration, and 30,000,000 restricted common shares to Roman Israel Wood in full settlement of compensation claims for services rendered to the Company. Management is evaluating the accounting and disclosure implications of these transactions.
| F-14 |
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking Statements
Except for statements of historical fact, the information presented herein constitutes forward-looking statements. These forward-looking statements generally can be identified by phrases such as “anticipates,” “believes,” “estimates,” “expects,” “forecasts,” “foresees,” “intends,” “plans,” or other words of similar import. Similarly, statements herein that describe our business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, our ability to: successfully commercialize our technology; generate revenues and achieve profitability in an intensely competitive industry; compete in products and prices with substantially larger and better capitalized competitors; secure, maintain and enforce a strong intellectual property portfolio; attract additional capital sufficient to finance our working capital requirements, as well as any investment in plant, property and equipment; develop a sales and marketing infrastructure, including e-commerce sales channels; identify and maintain relationships with third-party suppliers who can provide us a reliable source of products; attract and retain talented individuals; successfully complete our management and operational transition; continue operations during periods of uncertain general economic or market conditions; and other events, factors and risks previously and from time to time disclosed in our filings with the Securities and Exchange Commission. Although we believe the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on our forward-looking statements, which speak only as of the date of this report. Except as required by law, we do not undertake to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Overview
We were incorporated in the State of Nevada on June 6, 2007. On August 2, 2010, we changed our name from Bella Viaggio, Inc. to Kat Gold Holdings Corp. Effective January 1, 2015, we completed an exchange agreement to purchase 100% of the outstanding interests of REMSleep LLC in exchange for 50,000,000 shares of our common stock, at which time REMSleep LLC became our wholly-owned subsidiary and we adopted its business of developing and distributing sleep apnea products. On January 5, 2015, we changed our name to REMSleep Holdings, Inc. to reflect our new business model.
Our founders invented our DeltaWave CPAP interface (the “DeltaWave”) as an innovative new device to treat patients with sleep apnea. The DeltaWave is a nasal-pillows type interface designed to provide better comfort and, therefore, better compliance, as it was specifically designed with unique airflow characteristics to enable patients with sleep apnea to breathe normally. A survey that appeared in DME Business found that 89% of patients stated that mask-interface comfort was their primary concern. The primary issue that we have addressed with the DeltaWave is the “work of breathing” component. We believe that the DeltaWave is designed to effectively address the persistent issues that continue to affect a patient’s ability to comply with treatment, as it:
| • | Does not disrupt normal breathing mechanics; |
| • | Is not claustrophobic; |
| • | Causes zero work of breathing (WOB); |
| • | Minimizes or eliminates drying of the sinuses; |
| • | Uses less driving pressure; and |
| • | Allows users to feel safe and secure while sleeping. |
| 4 |
On April 27, 2021, we were awarded utility patent 10,987,481 for the DeltaWave CPAP pillows mask for delivery of CPAP therapy and other respiratory needs. On March 5, 2024, we were awarded design patent D1,017,025 S. Our goal is to continue to develop sleep products for the treatment of obstructive sleep apnea.
Recent Developments
On May 27, 2026, the Company experienced a change in control when 1000152403 Ontario Inc. acquired substantially all of the Company’s preferred stock control block, and the Company’s officers and directors were replaced. Beginning on or about June 1, 2026, under new management, the Company closed its former office in Blackshear, Georgia, relocated its principal office operations to Florida, and established a warehouse facility at 1900 6th Ave. South, Lake Worth, FL 33461. The Company is transitioning from its prior retail “cash and carry” walk-in model toward a business model focused on Internet e-commerce and e-retail sales channels such as eBay and similar e-tailers, launching nationwide and then expanding to international markets. On September 2, 2026, the Board approved the issuance of an aggregate of 45,000,000 restricted shares of common stock as described in Note 12 to the financial statements.
Our website is located at: https://remsleep.com. Information on our website is not part of this report.
Results of Operations
Three months ended September 30, 2026 compared to the three months ended September 30, 2025
Revenues. We had no revenue for the three months ended September 30, 2026, compared to revenue of $7,454 and cost of revenues of $28 for the three months ended September 30, 2025. The absence of revenue in the current period reflects the closing of our Georgia retail location and our transition to e-commerce sales channels, which had not yet generated sales during the quarter.
Operating Expenses. Total operating expenses were $49,637 for the three months ended September 30, 2026, compared to $2,290,695 for the three months ended September 30, 2025, a decrease of $2,241,058, or 97.8%. Operating expenses in the current quarter consisted entirely of general and administrative expenses. The prior-year quarter included compensation expense of $2,197,000, of which $2,160,000 represented the fair value of Series C preferred stock issued to a related party for services, together with professional fees of $11,750 and lease expense of $4,968. General and administrative expenses decreased by $27,340, or 35.5%, to $49,637 from $76,977, reflecting reduced activity during the relocation and business-model transition.
Other Income (Expense). Total other expense was $1,261 for the three months ended September 30, 2026, consisting of interest expense, compared to total other expense of $28,877 for the three months ended September 30, 2025, which consisted of interest expense of $130,133 and a loss on conversion of debt of $47,271, partially offset by a gain on the change in fair value of derivative liability of $148,527. The decrease in interest expense reflects the conversion of the 1800 Diagonal Lending LLC notes earlier in 2026 and of the Quick Capital, LLC note on August 17, 2026.
Net Loss. We had a net loss of $49,637 for the three months ended September 30, 2026, compared to a net loss of $2,312,146 for the three months ended September 30, 2025, for the reasons discussed above.
| 5 |
Nine months ended September 30, 2026 compared to the nine months ended September 30, 2025
Revenues. We had no revenue for the nine months ended September 30, 2026, compared to revenue of $12,278 and cost of revenues of $628, for a gross profit of $11,650, for the nine months ended September 30, 2025.
Operating Expenses. Total operating expenses were $280,985 for the nine months ended September 30, 2026, compared to $2,558,786 for the nine months ended September 30, 2025, a decrease of $2,277,801, or 89.0%, comprised of the following:
| Nine Months 2026 | Nine Months 2025 | Change ($) | Change (%) | |||||||||||||
| Professional fees | $ | 2,276 | $ | 47,300 | $ | (45,024 | ) | (95.2% | ) | |||||||
| Compensation expense | 44,140 | 2,248,000 | (2,203,860 | ) | (98.0% | ) | ||||||||||
| Development expenses | – | 18,700 | (18,700 | ) | (100.0% | ) | ||||||||||
| Lease expense | 4,800 | 31,459 | (26,659 | ) | (84.7% | ) | ||||||||||
| General and administrative expenses | 229,769 | 213,327 | 16,442 | 7.7% | ||||||||||||
| Total operating expenses | $ | 280,985 | $ | 2,558,786 | $ | (2,277,801 | ) | (89.0% | ) | |||||||
Professional fees, which consist mostly of accounting, audit and legal fees, decreased due to lower legal and consulting activity. Compensation expense in the current period consisted of amounts paid or accrued to our former Chief Executive Officer, Ms. Michaels and Mr. Marshall; the prior-year period included $2,160,000 of non-cash compensation from the issuance of Series C preferred stock to a related party for services. Development expenses decreased as development and testing of the DeltaWave product was completed. Lease expense decreased because we moved to a new, less expensive lease and subsequently closed our Georgia location. General and administrative expenses increased primarily due to product and selling expenses, including payments to outside salespeople, and costs associated with our relocation to Florida.
Other Income (Expense). Total other expense was $124,119 for the nine months ended September 30, 2026, which included interest expense of $52,578, a loss on issuance of convertible debt of $79,898 and a loss on conversion of debt of $28,146, partially offset by a gain on the change in fair value of derivative liability of $36,503. Total other expense was $138,270 for the nine months ended September 30, 2025, which included interest expense of $350,100, a loss on issuance of convertible debt of $118,654 and a loss on conversion of debt of $101,404, partially offset by a gain on the change in fair value of derivative liability of $431,888.
Net Loss. We had a net loss of $405,103 for the nine months ended September 30, 2026, compared to a net loss of $2,685,406 for the nine months ended September 30, 2025, a decrease of $2,280,303, for the reasons discussed above.
Liquidity and Capital Resources
As of September 30, 2026, we had cash of $23,947 and a working capital deficit of $218,608 (current assets of $96,803 less current liabilities of $315,411), compared to cash of $214,514 and a working capital deficit of $34,448 as of December 31, 2025. As of September 30, 2026, we had total stockholders’ deficit of $159,693.
Cash Flows from Operating Activities. Net cash used in operating activities was $403,915 for the nine months ended September 30, 2026, compared to $373,395 for the nine months ended September 30, 2025. Cash used in the current period reflects our net loss of $405,103, adjusted for non-cash items, together with an increase in inventory of $24,052 and a decrease in accounts payable of $9,529.
Cash Flows from Investing Activities. We had no investing activities during the nine months ended September 30, 2026 or 2025.
| 6 |
Cash Flows from Financing Activities. Net cash provided by financing activities was $213,348 for the nine months ended September 30, 2026, attributable to common stock issued of $167,827 and additional paid-in capital of $45,521, compared to $254,000 for the nine months ended September 30, 2025 from proceeds of convertible notes payable. During 2026, we also issued a $68,125 convertible note to Quick Capital, LLC, which the holder converted in full on August 17, 2026, and entered into a $40,000 convertible loan agreement with Fransys Consulting Inc.
Going Concern
As of September 30, 2026, there is substantial doubt regarding our ability to continue as a going concern, as we have not generated sufficient cash flow from revenue to fund our proposed business. We have suffered recurring losses from operations since our inception. In addition, we have yet to generate internal cash flow from our business operations or to successfully raise the financing required to develop our proposed business. As a result of these and other factors, our independent auditor has expressed substantial doubt about our ability to continue as a going concern. Our future success and viability are dependent upon our ability to generate capital financing. The failure to generate sufficient revenues or raise additional capital may have a material adverse effect upon us and our shareholders. Management plans to seek additional capital through private placements and public offerings of our common stock and through debt financing, and to grow revenue through our e-commerce sales channels; however, there can be no assurance that such efforts will be successful.
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
Critical Accounting Policies and Estimates
Refer to Note 2 to the financial statements included in this report for a discussion of our significant accounting policies, and to our Annual Report on Form 10-K for the year ended December 31, 2025 for a full discussion of our critical accounting policies and estimates.
| 7 |
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and, as such, are not required to provide the information under this Item.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our principal executive officer and principal financial officer has evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this quarterly report. Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of September 30, 2026 due to a lack of segregation of duties.
In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives. In addition, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs.
Changes in Internal Control over Financial Reporting
Our management has evaluated whether any change in our internal control over financial reporting occurred during the quarter ended September 30, 2026. Based on that evaluation, management concluded that there has been no change in our internal control over financial reporting during the quarter ended September 30, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
| 8 |
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None.
ITEM 1A. RISK FACTORS
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and, as such, are not required to provide the information under this Item.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
On September 2, 2026, the Board of Directors approved the issuance of 15,000,000 restricted shares of common stock to Scott Hasselbring for services related to asset preservation and estate administration, and 30,000,000 restricted shares of common stock to Roman Israel Wood in full settlement of compensation claims for services rendered to the Company. The shares were or will be issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, as transactions by an issuer not involving a public offering. No cash proceeds were received.
On August 17, 2026, Quick Capital, LLC converted its 10% Convertible Promissory Note issued January 27, 2026 in the original principal amount of $68,125 into 132,406,619 shares of common stock. The shares were issued in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended. No additional consideration was received.
Other than as set forth above and as previously reported in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, there were no unregistered sales of equity securities during the quarter ended September 30, 2026.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
The Company previously disclosed certain matters relating to the change in control, management changes and compensatory arrangements in a Current Report on Form 8-K filed with the Securities and Exchange Commission on June 4, 2026. Such disclosures are incorporated herein by reference.
During the quarter ended September 30, 2026,
| 9 |
ITEM 6. EXHIBITS
The following exhibits are filed or furnished with this report:
| Exhibit No. | Description | |
| 31.1 | Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1 | Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101.INS | Inline XBRL Instance Document | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
| 10 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| REMSLEEP HOLDINGS, INC. | |
| Date: November 20, 2026 |
By: /s/ Sanja Pekovic Sanja Pekovic Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer) |
| Date: November 20, 2026 |
By: /s/ Teresita Rubio Teresita Rubio Chairman of the Board |
| 11 |